GlobeNewswire
-
Azora Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
19/11/2026 -
GATC Health Joins Bipartisan Panel at U.S. Capitol on the Future of Human-Relevant Drug Development
19/11/2026 -
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
19/11/2026 -
Palvella Therapeutics Announces QTORIN™ Docetaxel, a New QTORIN™ Program for the Treatment of Extramammary Paget’s Disease (EMPD)
19/11/2026 -
Clearmind Medicine Expands PTSD Patent Portfolio with Hong Kong Patent Application Publication
19/11/2026 -
Trading by management and close relations of management
19/11/2026 -
Actinogen pivotal Alzheimer’s disease trial demonstrates clinical benefit in older patients with mild to moderate disease, favorable safety profile and trends towards benefit in the overall population
19/11/2026 -
Humacyte Submits Supplemental Biologics License Application to FDA for the Acellular Tissue Engineered Vessel in Dialysis Access
19/11/2026 -
New National Survey Found Many People With Sleep Apnea Struggle to Stay on Treatment
19/11/2026 -
Bluesight Tracks 340B Dollars from Invoice to Rebate as 2027 Brings New Financial and Operational Challenges
19/11/2026 -
HYTN Innovations Inc. and Peptide Development Labs Inc. Announce Closing of the Arrangement and Concurrent Financing
19/11/2026 -
Phathom Pharmaceuticals Marks GERD Awareness Week 2026 by Urging Americans to Take Frequent Heartburn Seriously
19/11/2026 -
IRulya Therapeutics to Participate in the 9th Annual Evercore Healthcare Conference
19/11/2026 -
Altimmune to Participate in the 9th Annual Evercore Healthcare Conference
19/11/2026 -
Tvardi Therapeutics Advances Next-Generation Oral STAT3 Inhibitor TTI-109 Toward IND in Inflammatory Bowel Disease Following FDA Pre-IND Feedback
19/11/2026 -
Chemomab Therapeutics Announces Third Quarter 2026 Financial Results and Provides Corporate Update
19/11/2026 -
ITM and AtomVie Global Radiopharma Enter Supply Agreement for n.c.a. Lutetium-177
19/11/2026 -
Harmony Biosciences to Participate in Upcoming Investor Conferences
19/11/2026 -
VivoSim Labs Signs Seven-Figure Agreement with a Top-10 Global Pharmaceutical Company; Expects to Exceed Its 500%+ Revenue Growth Guidance for Fiscal 2027
19/11/2026
Pages